Frejo L, Martin-Sanz E, Teggi R, Trinidad G, Soto-Varela A, Santos-Perez S, Manrique R, Perez N, Aran I, Almeida-Branco M S, Batuecas-Caletrio A, Fraile J, Espinosa-Sanchez J M, Perez-Guillen V, Perez-Garrigues H, Oliva-Dominguez M, Aleman O, Benitez J, Perez P, Lopez-Escamez J A
Otology & Neurotology Group CTS495, Department of Genomic Medicine- Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Department of Otolaryngology, Hospital Universitario de Getafe, Getafe, Spain.
Clin Otolaryngol. 2017 Dec;42(6):1172-1180. doi: 10.1111/coa.12844. Epub 2017 Feb 26.
To define clinical subgroups by cluster analysis in patients with unilateral Meniere disease (MD) and to compare them with the clinical subgroups found in bilateral MD.
A cross-sectional study with a two-step cluster analysis.
A tertiary referral multicenter study.
Nine hundred and eighty-eight adult patients with unilateral MD.
best predictors to define clinical subgroups with potential different aetiologies.
We established five clusters in unilateral MD. Group 1 is the most frequently found, includes 53% of patients, and it is defined as the sporadic, classic MD without migraine and without autoimmune disorder (AD). Group 2 is found in 8% of patients, and it is defined by hearing loss, which antedates the vertigo episodes by months or years (delayed MD), without migraine or AD in most of cases. Group 3 involves 13% of patients, and it is considered familial MD, while group 4, which includes 15% of patients, is linked to the presence of migraine in all cases. Group 5 is found in 11% of patients and is defined by a comorbid AD. We found significant differences in the distribution of AD in clusters 3, 4 and 5 between patients with uni- and bilateral MD.
Cluster analysis defines clinical subgroups in MD, and it extends the phenotype beyond audiovestibular symptoms. This classification will help to improve the phenotyping in MD and facilitate the selection of patients for randomised clinical trials.
通过聚类分析确定单侧梅尼埃病(MD)患者的临床亚组,并将其与双侧MD患者的临床亚组进行比较。
采用两步聚类分析的横断面研究。
一项三级转诊多中心研究。
988例成年单侧MD患者。
确定具有潜在不同病因的临床亚组的最佳预测因素。
我们在单侧MD中确定了五个聚类。第1组最为常见,包括53%的患者,其定义为散发性、典型MD,无偏头痛且无自身免疫性疾病(AD)。第2组见于8%的患者,其定义为听力损失,在眩晕发作前数月或数年出现(迟发性MD),大多数情况下无偏头痛或AD。第3组涉及13%的患者,被认为是家族性MD,而第4组包括15%的患者,在所有病例中均与偏头痛有关。第5组见于11%的患者,由合并AD定义。我们发现单侧和双侧MD患者在第3、4和5组中AD的分布存在显著差异。
聚类分析确定了MD的临床亚组,并将表型扩展到听觉前庭症状之外。这种分类将有助于改善MD的表型分析,并便于为随机临床试验选择患者。